263 related articles for article (PubMed ID: 21118970)
21. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion.
Sengupta S; Kim KS; Berk MP; Oates R; Escobar P; Belinson J; Li W; Lindner DJ; Williams B; Xu Y
Oncogene; 2007 May; 26(20):2894-901. PubMed ID: 17130843
[TBL] [Abstract][Full Text] [Related]
22. An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin-polymerizing machine.
Scita G; Tenca P; Areces LB; Tocchetti A; Frittoli E; Giardina G; Ponzanelli I; Sini P; Innocenti M; Di Fiore PP
J Cell Biol; 2001 Sep; 154(5):1031-44. PubMed ID: 11524436
[TBL] [Abstract][Full Text] [Related]
23. Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.
Jeong KJ; Park SY; Seo JH; Lee KB; Choi WS; Han JW; Kang JK; Park CG; Kim YK; Lee HY
Exp Mol Med; 2008 Dec; 40(6):607-16. PubMed ID: 19116446
[TBL] [Abstract][Full Text] [Related]
24. Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway.
Bian D; Su S; Mahanivong C; Cheng RK; Han Q; Pan ZK; Sun P; Huang S
Cancer Res; 2004 Jun; 64(12):4209-17. PubMed ID: 15205333
[TBL] [Abstract][Full Text] [Related]
25. Eps8 in the midst of GTPases.
Di Fiore PP; Scita G
Int J Biochem Cell Biol; 2002 Oct; 34(10):1178-83. PubMed ID: 12127568
[TBL] [Abstract][Full Text] [Related]
26. β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1.
Alemayehu M; Dragan M; Pape C; Siddiqui I; Sacks DB; Di Guglielmo GM; Babwah AV; Bhattacharya M
PLoS One; 2013; 8(2):e56174. PubMed ID: 23405264
[TBL] [Abstract][Full Text] [Related]
27. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Fan Q; Cai Q; Xu Y
Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
[TBL] [Abstract][Full Text] [Related]
28. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
Lee Z; Swaby RF; Liang Y; Yu S; Liu S; Lu KH; Bast RC; Mills GB; Fang X
Cancer Res; 2006 Mar; 66(5):2740-8. PubMed ID: 16510595
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: a focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays.
Willier S; Butt E; Grunewald TG
Biol Cell; 2013 Aug; 105(8):317-33. PubMed ID: 23611148
[TBL] [Abstract][Full Text] [Related]
30. TAZ mediates lysophosphatidic acid-induced migration and proliferation of epithelial ovarian cancer cells.
Jeong GO; Shin SH; Seo EJ; Kwon YW; Heo SC; Kim KH; Yoon MS; Suh DS; Kim JH
Cell Physiol Biochem; 2013; 32(2):253-63. PubMed ID: 23942151
[TBL] [Abstract][Full Text] [Related]
31. Palladin binds to Eps8 and enhances the formation of dorsal ruffles and podosomes in vascular smooth muscle cells.
Goicoechea S; Arneman D; Disanza A; Garcia-Mata R; Scita G; Otey CA
J Cell Sci; 2006 Aug; 119(Pt 16):3316-24. PubMed ID: 16868024
[TBL] [Abstract][Full Text] [Related]
32. A MAPK-Driven Feedback Loop Suppresses Rac Activity to Promote RhoA-Driven Cancer Cell Invasion.
Hetmanski JH; Zindy E; Schwartz JM; Caswell PT
PLoS Comput Biol; 2016 May; 12(5):e1004909. PubMed ID: 27138333
[TBL] [Abstract][Full Text] [Related]
33. Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect.
E S; Lai YJ; Tsukahara R; Chen CS; Fujiwara Y; Yue J; Yu JH; Guo H; Kihara A; Tigyi G; Lin FT
J Biol Chem; 2009 May; 284(21):14558-71. PubMed ID: 19293149
[TBL] [Abstract][Full Text] [Related]
34. Essential role for Abi1 in embryonic survival and WAVE2 complex integrity.
Dubielecka PM; Ladwein KI; Xiong X; Migeotte I; Chorzalska A; Anderson KV; Sawicki JA; Rottner K; Stradal TE; Kotula L
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7022-7. PubMed ID: 21482783
[TBL] [Abstract][Full Text] [Related]
35. The lysophosphatidic acid-regulated signal transduction network in ovarian cancer cells and its role in actomyosin dynamics, cell migration and entosis.
Ojasalu K; Lieber S; Sokol AM; Nist A; Stiewe T; Bullwinkel I; Finkernagel F; Reinartz S; Müller-Brüsselbach S; Grosse R; Graumann J; Müller R
Theranostics; 2023; 13(6):1921-1948. PubMed ID: 37064875
[TBL] [Abstract][Full Text] [Related]
36. Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer.
Ha JH; Radhakrishnan R; Nadhan R; Gomathinayagam R; Jayaraman M; Yan M; Kashyap S; Fung KM; Xu C; Bhattacharya R; Mukherjee P; Isidoro C; Song YS; Dhanasekaran DN
Cancer Lett; 2024 Jun; 591():216891. PubMed ID: 38642607
[TBL] [Abstract][Full Text] [Related]
37. SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk.
Said NA; Najwer I; Socha MJ; Fulton DJ; Mok SC; Motamed K
Neoplasia; 2007 Jan; 9(1):23-35. PubMed ID: 17325741
[TBL] [Abstract][Full Text] [Related]
38. The gep proto-oncogene Gα13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells.
Gardner JA; Ha JH; Jayaraman M; Dhanasekaran DN
Pancreas; 2013 Jul; 42(5):819-28. PubMed ID: 23508014
[TBL] [Abstract][Full Text] [Related]
39. Eps8 is recruited to lysosomes and subjected to chaperone-mediated autophagy in cancer cells.
Welsch T; Younsi A; Disanza A; Rodriguez JA; Cuervo AM; Scita G; Schmidt J
Exp Cell Res; 2010 Jul; 316(12):1914-24. PubMed ID: 20184880
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer.
Ha JH; Yan M; Gomathinayagam R; Jayaraman M; Husain S; Liu J; Mukherjee P; Reddy EP; Song YS; Dhanasekaran DN
Oncotarget; 2016 Nov; 7(45):72845-72859. PubMed ID: 27655714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
